Mesothelioma: Current Perspectives
|
|
- Olivia Hunt
- 8 years ago
- Views:
Transcription
1 Refer to: Taylor RA, Johnson LP: : Current J>cr-, jpcclivej. West J Med 13<:37WS3. May ". «.' /^ - <"-- t i : i r?> THEWESTEEN Journal of Medicine X'<2A-ftS6E-STQS PAP" A : Current Perspectives F^ ^, LLOYD P. JOHNSON, MD, Seattle^. A~ X\~ G^^J^j? ROY A. TAYLOR, MD, and Thirty patients with the diagnosis of mesothelioma were admitted to the Swedish Hospital Medical Center, Seattle, from 1975 to Of these, 26 had pleural and 4 had peritoneal mesothelioma. In 20 of the patients with pleural mesothelioma, the diagnosis had been made by open thoractomy and in only one by needle biopsy of the pleura. The average survival of the patients with pleural tumors from time of diagnosis was 15 months, and two are alive at th'ree and eight months, respectively, one of whom had an apparent solitary benign mesothelioma. The average survival of those with peritoneal mesothelioma was ten months, although one has survived six years. There were 17 patients with a known history of exposure to asbestos, 14 while working in shipyards. Because of the relatively high incidence of this previously rare tumor in the Puget Sound, Washington, area, and the generally dismal results of therapy, better methods of diagnosis including thoracoscopy and a more systematic approach to treatment are recommended. IN RECENT YEARS, mesothelioma, a tumor of serosal surfaces, has become a subject of growing interest among the medical profession and the lay public. The attention is due both to its increasing frequency of diagnosis and its strong epidemiological link to asbestos exposure. 1-7 Asbestos, a mineral fiber, is valued for its thermal properties and has found wide application in this century as an insulating material. Until recently, including the busy years of World War II. it was used extensively in ship building as pipe insulation. Growing evidence indicates that the populations in those areas with ship building activities have a significantly increased risk of developing mesothelioma.'-" In a tumor registry study by Hinds" of eight areas of the United States, the Puget From the Department of Surpcrv. the Swedish Hospital Medical Center. Seattle (Dr Taylor), and the Department of Surtrery. University or Washington School of Medicine. Seattle (Dr. Johnson). Submitted Scrlember Reprint requests to: Lloyd P. Johnson, MD. Seattle Surpical Group, rnc, P.S., 801 Broadway. Suite 901, Seattle. WA Sound area and New Orleans,, both with substantial shipyard activity, had the highest incidence of mesothelioma. During the past 4!/i years, one registry reported 85 cases of malignant pleural mesothelioma in western Washington (written communication, June 1980, Fred Hutchinson Cancer Research Center, Seattle). Because of this somewhat unusual epidemiology ' the apparent increasing incidence of the disease and the generally poor results of therapy, we wish to review our recent experience with mesothelioma and propose some new directions for its diagnosis and management. Clinical Presentation The cases of 30 patients admitted to the Swedish Hospital Medical Center in Seattle between 1975 and 1979 were reviewed. In all of the patients mesothelioma had been diagnosed by tissue analysis. There were 25 with diffuse malignant pleural disease, 4 with peritoneal tumor and 1 THE WESTERN JOURNAL OF MEDICINE 379 TI
2 N/ with a benign localized pleural mesothelioma (Table 1). Peritoneal Three of the four patients with peritoneal mesothelioma were men. The average ace at diagnosis was 59 years. Two patients had a known history of exposure to asbestos, one of these had worked in shipyards 25 years earlier. The most common symptoms were abdominal pain, loss of weight, abdominal distension and fever. Three of the patients had ascites and in one of these a gallium scan and abdominal ultrasound examination showed abnormalities. Paracentesis was carried out in two but was diagnostic in neither. Laparotomy was required for diagnosis in all four patients. The tumor was described as being diffuse with matting of the bowel in three patients. One patient had metastasis to the liver, lung and scalene nodes. Two of the patients died two weeks after diagnosis and a third died after nine months. Of interest, the fourth patient was a woman who had a predominant pelvic tumor with involvement of the colon and uterus as Well as omental nodules. She was treated by resection of the tumor, followed by radiation and chemotherapy. She is still alive six years after the time of diagnosis, and there is no evidence of recurring disease. Benign Pleural In the one patient with benign localized pleural mesothelioma, an asymptomatic mass of the left side was detected on an x-ray study of the chest- Over five years the lesion increased in size from 2 to 8 cm (see Figure 1). She had no history of asbestos exposure. During thoracotomy a solitary benign mesothelioma was found and was removed without difficulty. The patient is doing well six months following resection, and there is no evidence of recurrent tumor. Malignant Pleural Twenty of 25 patients with diffuse pleural mesothelioma were men. The average age at diagnosis was 61 years. Fifteen patients had a known exposure to asbestos, 13 of them in shipyards. The average interval from time of exposure to diagnosis was 32 years. The clinical presentation of these cases is given in Table 1. The most common symptoms were chest pain and dyspnea. Pleural effusion was TABLE 1. Clinical Symptoms ol 25 Patients With Dilluse Pleural Disease',Vo. o/ Patients Symploms Dyspnea II Chest pain 9 Weakness 7 Fever 7 Findings on roentgenograms Pleural effusion 20 Pleural nodularity 11 In one olhcr patient with pleural mesothelioma, the condition was diagnosed as a solitary benign tumor. Figure 1. X-ray studies ol the chest showing growth of a benign pleural mesothelioma from 2 to 8 cm over five years. 380 MAY T
3 present in 20 of 25 patients. The common findings on chest roentgenograms, as represented in Figure 2, included pleural effusion, pleural nodules demonstrated best by pneumothorax and pleural plaques, which were calcified and probably benign. Diagnostic procedures are listed in Table 2. In 19 patients a diagnosis was made by thoracotomy. Cytologic studies of pleural fluid and needle biopsies of the pleura have not been productive. Recently, thoracoscopy, using the mediastinoscope, produced good visualization of large areas of the parietal, visceral and diaphragmatic pleura in two patients and allowed adequate biopsy studies of the pleural nodules. At thoracoiomy or thoracoscopy the pleura appears as a thickened, nodular rind, constricting and compressing the lung. A typical specimen removed by total pleureciomy is shown in Figure 3. Results Results of treatment of diffuse pleural mesothelioma are shown in Figure 4. The average length of survival after diagnosis was 15 months: One patient, who had been treated by total pleurectomy, survived for five years without evidence of recurrent tumor but subsequently died of a primary adenocarcinoma of the lung. Chemotherapy in 15 patients consisted of various combinations of doxorubicin, vincristine, cyclophosphamide, actinomycin-d, rubidazone and dacarbazine; however, these drugs did not appear to significantly alter the progression of the disease. Radiotherapy also appeared to be of little benefit in seven patients. Discussion The present series of patients bears out the strong relationship of pleural mesothelioma to asbestos exposure and probably reflects the substantial shipyard activity in the Pugct Sound area. The long latency 32 years between last known exposure and diagnosis is in agreement with other series and is of concern because significant exposure to abestos by certain occupational groups still continues. 7 Since Wagner and co-workers first reported the relntionship between asbestos exposure and mesothelioma in I960, numerous reports have appeared describinc the high incidence, not only of mesothelioma, but also of bronchogenic, oropharyngeal, laryngeal, gastrointestinal and renal tumors among those who have been exposed to asbestos. 1 -''-" Lung cancer death rates may be increased to 60 times those of controls by asbestos exposure and cigarette /smoking.', TABLE 2. Method o/ Diagnosis in 25 Patients With Dittuse Pleural Disease Method No. of Patients Thoractomy 19 Needle biopsy of pleura (5 attempted)... 1 Cytology (II attempted) I Thoracoscopy 1 Unknown 2 * Figure 2. X-ray studies of the j chest showing typical findings in diffuse pleural mesothelioma: pleural effusion, pleural nodules and pleural plaques. THE WESTERN JOURNAL OF MEDICINE 381 TI
4 V' however, has no appcarant relationship to cigarette smoking.* Solitary benign tumors have not been shown to be related to asbestos exposure and are almost always cured by local resection.' 0-12 Their major significance is in the occasional production of local symptoms and the difficulty of differentiating them from malignant lesions of the lung or mediastinum. Peritoneal mesothelioma has a worse prognosis than diffuse pleural disease, with an average survival rate of three months to a year following diagnosis."-" As occurred in this series, however, there may be an occasional patient with a predominant mass that resembles mesothelioma histologically, who may be cured by resection of the tumor combined with chemotherapy and radiation. Although others have reported good results in diagnosing diffuse pleural disease by obtaining blind needle biopsies of the pleura or doing cytologic studies of pleural fluid, 0 -' 5-10 these techniques were not productive in the present series. Thoracotomy was used to make the diagnosis in most patients in this group, although, recently, thoracoscopy was used successfully with minimal morbidity in two patients. The latter is certainly not a new procedure and has been reported previously in the diagnosis of mesothelioma; however, this is the first known report using a rigid mediastinoscope. 17 Although the survival rate of the patients in our series is similar to that of others, these studies represent a somewhat heterogenous approach to therapy by a number of physicians."-'"-" 1 Wanebo and colleagues," 1 using plcurectomy with or without radiation and chemotherapy, reported 5-year survival of 5 of 33 patients with diffuse pleural mesothelioma. DcLaria and co-workers'" reported 11 patients having radical plcuropncumoncctomy, witli two surviving after two and four years, respectively. Schlienger and colleagues'-" reported a median survival of 13 months in patients treated with megavoltage radiotherapy to one hemithorax compared with 9.8 months survival in those receiving no radiation. Chemotherapy, using doxorubicin in combination with various other drugs, has been reported to induce a response rate of 20 percent to 40 percent in some patients."! - " Thus, there is evidence that all three modalities surgical procedures, radiation and chemotherapy 100 PLEURAL no. of months Alt p«ti»ms Figure 4. Survival curve ot all 25 patients with diffuse pleural mesothelioma, ranging from 2 to 60 months from time of diagnosis. Figure 3. Gross specimen of diffuse pleural mesothelioma, removed by total pleurectomy, showing irregular, fibronodular appearance of pleura. 382 MAY TI
5 \7 may benefit patients with pleural mesothelioma. Intensive combined therapy using all three modalities is under way as an intercooperative group study, involving plcurcctomy (recommended) and radiotherapy to 4,700 rads with or without doxorubicin therapy. (Written communication, June 1980; L. Wasser, L. Baker and M. Samson: Radiotherapy With and Without Chemotherapy for Malignant Pleural Localized to One Hemithorax [Intergroup Study] Eastern and Southwest Oncology Groups.) We recommend this protocol. Only with a prospective randomized clinical trial will the effects of the combined-modality treatment be measurable. REFERENCES 1. McDonald JC. MacDonald AD: Epidemiology of mesothelioma from estimated incidence. Prevcnl Med 6: , Wagner JC. Slcggs CA, Marchand P: Diffuse pleural mesothelioma and asbestos exposure in the Northwestern Cape Province. Br J lndustr Med 17: Theriault GP, Crand-Bois L: and asbestos in the Province of Quebec, Arch Environ Health 33: Jan-Feb Ncwhousc ML. Berry G: Predictions of mortality from mesothelial tumors in asbestos factory workers. Br J lndustr Med 33: , Aug Borrow M. Conston A. Livornese L, et al: following-exposure to asbestos: A review of 72 cases. Chest 64: , Nov Edge JR. Choudhury SL: Malignant mesothelioma of the pleura in Barrow-in-Furness. Thorax 33:26-3D, Feb Chovil A. Stewart C: Latency period for mesothelioma. Lancet 2:S53. Oct Hinds MW: in the United States Incidence in the 1970s. J Occupat Med , Jul 197S 9. Selikoff )J. Hammond EC: Asbestos and smoking (Editorial). JAMA 242:458. Aug Scharifker D, Kaneko M: Localized fibrous "mesothelioma'* of pleura (submesothelial fibroma) A ciinicopathologic study of 18 cases. Cancer 43: Feb Shabanah FH. Saycgh SF: Solitary (localized) pleural mesothelioma Report of two cases and review of the literature. Chest Dec Utley JR. Parker JC. Hahn RS. et al: Recurrent benign fibrous mesothelioma of the pleura. J Thorac Cardiovasc Surg 65: May Kannerstcin M. Churg J: Peritoneal mesothelioma. Human Pathol 8: Jan Jones DEC, Silver D: Peritoneal mesothelioma. Surgery 86: Oct FU12cr ER. Pool JL. Melamed MR: Pleural mesotheliomas Clinical experiences with thirty-seven patients. Am J Roentgenol 99: Apr Oels HC, Harrison EG, Carr DT. et al: Diffuse malignant mesothelioma of the pleura: A review of 37 cases. Chest 6: , Dec Boushy SF, North LB, Helgason AA: Thoracoscopy: Technique and results in eighteen patients with pleural effusion. Chest 74: Oct Wanebo HJ. Martini N. Melamed MR. et al: Pleural mesothelioma. Cancer 38: , Dec DcLaria GA, Jcnsik R. Fabcr LP, et al: Surgical management of malignant mesothelioma. Ann Thorac Surg 26: , Oct Schliengcr M. Eschwege F. Blache R. et al: Mesolheliomes pleuraux malins. Bull Cancer (Paris) 56: , Sprcmulli E, Wampicr G, Regelson W, el al: Chemotherapy of malignant mesothelioma. Cancer 40: Nov Yap B, Benjamin RS. Burgess MA. et al: The value of -adrtamycin in the treatment of diffuse malignant pleural mesothelioma. Cancer 42: Oct Chahinian AP. Suzuki Y. Mandel EM. et al: Diffuse pulmonary malignant mesothelioma Response to doxorubicin and 5-azacytidlne. Cancer 42: , Oct 1978
Survey of Mesothelioma Associated with Asbestos Exposure in Japan
The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics
More informationMesothelioma: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
More informationMesothelioma. 1. Introduction. 1.1 General Information and Aetiology
Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis [1]. Most are
More informationObjectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
More informationMesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1
Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this
More informationبسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
More informationMalignant Mesothelioma
Malignant Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
More informationMalignant Mesothelioma
Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
More informationLung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.
Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette
More informationDisease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
More informationMesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology
MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image
More informationPrimary -Benign - Malignant Secondary
TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low
More informationSummary of treatment benefits
Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell
More informationThe Need for Accurate Lung Cancer Staging
The Need for Accurate Lung Cancer Staging Peter Baik, DO Thoracic Surgery Cancer Treatment Centers of America Oklahoma Osteopathic Association 115th Annual Convention Financial Disclosures: None 2 Objectives
More informationWhat is Mesothelioma?
What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and
More informationEpidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD
Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of
More informationtreated and 64 untreated patients
Thorax 1984;39:255-259 Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients MR LAW, ANNA GREGOR, MARGARET E HODSON, HJG BLOOM, M TURNER-WARWICK From the Cardiothoracic
More informationSir William Osler: Listen to the patient; the patient tells you everything.
Sir William Osler: Listen to the patient; the patient tells you everything. Jean-Martin Charcot: The patient is a liar. Epidemiology of Mesothelioma Jeffrey H. Mandel, MD, MPH Division of Environmental
More informationClinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines
Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year
More informationExtrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos
More informationAsbestos Related Diseases
Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through
More informationMale. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
More informationDiseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours
Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains
More informationMalignant Mesothelioma: an Update
Malignant Mesothelioma: an Update Nico van Zandwijk Asbestos Diseases Research Institute Bernie Banton Centre University of Sydney Australia Physicians Week RACP 19-5-2009 Health Risks of Asbestos Fibers
More informationAsbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating
Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease connecting raising awareness supporting advocating 1800 017 758 www.asbestosassociation.com.au Asbestos lagging was widely
More informationUnderstanding Pleural Mesothelioma
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
More informationRound Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma
Round Table with Drs. Anne Tsao and Alex Farivar, Case 2: Mesothelioma I d like to welcome everyone, thanks for coming out to our lunch with experts. The faculty today are great people in the thoracic
More informationColumbia University Mesothelioma Applied Research Foundation - 2009 - www.curemeso.org. Mesothelioma Center www.mesocenter.org
Columbia University Mesothelioma Center www.mesocenter.org Multimodal clinical trials, treatment (surgery, radiation, chemotherapy) Peritoneal mesothelioma program Immunotherapy translational, experimental
More informationAsbestos and your lungs
This information describes what asbestos is and the lung conditions that are caused by exposure to it. It also includes information about what to do if you have been exposed to asbestos, and the benefits
More informationGUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
More informationHow To Understand How Cancer Works
Mesothelioma Understanding your diagnosis Mesothelioma Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount of
More informationPET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1. Jonathan C. Daniel 2. Kenneth S.
PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1 Jonathan C. Daniel 2 Kenneth S. Knox 1 Kathleen Williams 1 Departments of Medicine 1 and Surgery 2, University
More informationASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3
ASBESTOS EXPOSURE AND SARCOMATOID MALIGNANT PLEURAL MESOTHELIOMA Gorantla Sambasivarao 1, Namballa Usharani 2, Tupakula Suresh Babu 3 HOW TO CITE THIS ARTICLE: Gorantla Sambasivarao, Namballa Usharani,
More informationSMALL CELL LUNG CANCER
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
More informationINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
More informationPre-workshop exercise
Setting research priorities for mesothelioma workshop 10 th November 2014 Pre-workshop exercise Your individual ranking of unanswered questions about the diagnosis, treatment and care of mesothelioma Please
More informationHEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.
HEALTH CARE FOR PATIENTS WITH EXPOSURE TO ASBESTOS 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.ca HEALTH CARE FOR PATIENTS WITH EXPOSURE
More informationUpdate on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
More informationAsbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer
Asbestos Health Risks Dr Andrew Pengilley Acting Chief Health Officer Asbestos Asbestos is a name given to several different fibrous minerals Three main commercial types are Chrysotile (white asbestos)
More informationL Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
More informationPATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*
PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON* M. L. Newhouse TUC Centenary Institute of Occupational Health London School of Hygiene and Tropical Medicine London WCIE 7HT. England G. Berry
More informationTherapy of pleural effusions Modern techniques
Therapy of pleural effusions Modern techniques Dr. Melanie Toffel Sugery of the chest Pleural effusion Ethiology In the normal pleural space there is a steady state in which there is a roughly equal rate
More informationMesothelioma. Malignant Pleural Mesothelioma
Mesothelioma William G. Richards, PhD Brigham and Women s Hospital Malignant Pleural Mesothelioma 2,000-3,000 cases per year (USA) Increasing incidence Asbestos (50-80%, decreasing) 30-40 year latency
More informationMalignant Mesothelioma State of the Art
Malignant Mesothelioma State of the Art Paul Baas The Netherlands Cancer Institute August 12, 2011, Carlsbad, CA Summary Diagnosis; epithelial type subdivided Pleiomorphic vs other Staging: IASLC-IMIG
More informationNeoplasms of the LUNG and PLEURA
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
More informationHow To Treat Lung Cancer At Cleveland Clinic
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
More informationMalignant Mesothelioma Current Approaches to a Difficult Problem. Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center
Malignant Mesothelioma Current Approaches to a Difficult Problem Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center Malignant Pleural Mesothelioma Clinical Presentation Insidious
More informationAsbestos related health risks
Asbestos related health risks Pascal DUMORTIER *,** & Paul DE VUYST** *a-ulab ** Chest Department Hopital ERASME Asbestos related health risks Asbestos : some facts Asbestos related diseases Detection
More informationWA Asbestos Review Program
WA Asbestos Review Program Dr Fraser Brims Consultant Respiratory Physician, SCGH, Head of Occupational and Respiratory Health Unit, LIWA Asbestos awareness week seminar, 2014 Introduction Asbestos and
More informationAsbestos related cancers
New cancer cases 1954-215 in Finland, Men Pukkala et al. 26 Asbestos related cancers Panu Oksa, MD, docent Course on asbestos-related diseases Tartu 4-5.12.26 Asbestos related cancer / FIOH / PO / 1.1.27
More informationUses and Abuses of Pathology in Asbestos-exposed Populations
Uses and Abuses of Pathology in Asbestos-exposed Populations Jerrold L. Abraham, MD Department of Pathology State University of New York Upstate Medical University Syracuse, NY, 13210 USA The term: Asbestosis,
More informationMalignant mesothelioma in a cohort of asbestos
British Journal ofindustrial Medicine 1988;45:182-187 Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death J RIBAK, RUTH LILIS, Y SUZUKI,
More informationScientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York www.ierfinc.
Scientific Update on Safe Use of Asbestos Robert P. Nolan, PhD International Environmental Research Foundation New York, New York www.ierfinc.org When We Talk about Asbestos What Do We Mean? Anthophyllite
More informationJ of Evidence Based Med & Hlthcare, pissn- 2349-2562, eissn- 2349-2570/ Vol. 2/Issue 33/Aug. 17, 2015 Page 5063
PERITONEAL MALIGNANT MESOTHELIOMA: A RARE S. R. Dhamotharan 1, S. Shanthi Nirmala 2, F. Celine Foustina Mary 3, M. Arul Raj Kumar 4, R. Vinothprabhu 5 HOW TO CITE THIS ARTICLE: S. R. Dhamotharan, S. Shanthi
More informationMalignant pleural mesothelioma P/D vs. EPP
3 rd International Thoracic Oncology Congress Dresden, September 13 15, 2012 Malignant pleural mesothelioma P/D vs. EPP Walter Weder, MD Professor of Surgery Dokumentenname Datum Seite 1 Extrapleural Pneumonectomy
More informationMalignant Mesothelioma
Malignant Mesothelioma What is malignant mesothelioma? Malignant mesothelioma is a cancer that starts in cells in the linings of certain parts of the body, especially in the linings of the chest or abdomen.
More informationSmall Cell Lung Cancer
Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually
More informationKidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
More informationSternotomy and removal of the tumor
Sternotomy and removal of the tumor All thymomas originate from epithelial thymic cells 4% of them consist of a pure population of epithelial cells Most have mixed populations of lymphoid cells to a
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationCase Report Pleural Mesothelioma Presenting as Periumbilical Metastasis: The First Clinical Documentation
Volume 2013, Article ID 198729, 4 pages http://dx.doi.org/10.1155/2013/198729 Case Report Pleural Mesothelioma Presenting as Periumbilical Metastasis: The First Clinical Documentation R. F. Falkenstern-Ge,
More informationHow To Prevent Asbestos Related Diseases
BD5.3 Report of Working Groups Elimination of Asbestos-related Diseases ICOH 2012 March 18, 2012 Cancun Report of WG Elimination of Asbestos-related Diseases Dr. Sherson mail to ICOH President of 7 December
More informationAsbestos and the diseases it causes
Asbestos and the diseases it causes October 2013 Liz Darlison Mesothelioma UK University Hospitals of Leicester Contents What is asbestos Why is it such an issue in the UK Disease Statistics Asbestos Related
More informationWORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014
More informationFREQUENTLY ASKED QUESTIONS about asbestos related diseases
FREQUENTLY ASKED QUESTIONS about asbestos related diseases 1. What are the main types of asbestos lung disease? In the human body, asbestos affects the lungs most of all. It can affect both the spongy
More informationMalignant Mesothelioma
Malignant Mesothelioma What is malignant mesothelioma? Malignant mesothelioma is a cancer that starts in cells in the linings of certain parts of the body, especially in the linings of the chest or abdomen.
More informationHamers S O L I C I T O R S. Jim Wyatt jwyatt@hamers.com. Freephone: 0800 591 999. 5 Earls Court, Priory Park, East, Hull HU4 7DY
Hamers S O L I C I T O R S Jim Wyatt jwyatt@hamers.com Freephone: 0800 591 999 5 Earls Court, Priory Park, East, Hull HU4 7DY Tel: 01482 326666 Fax: 01482 324432 www.hamers.com Hamers Solicitors LP is
More informationLung cancer forms in tissues of the lung, usually in the cells lining air passages.
Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)
More informationLessons learned from the Western Australian experience with mesothelioma
Lessons learned from the Western Australian experience with mesothelioma Alison Reid, Western Australian Institute for Medical Research In partnership with Nick de Klerk, Nola Olsen, Jan Sleith, Geoffrey
More informationAvastin: Glossary of key terms
Avastin: Glossary of key terms Adenocarcinoma Adenoma Adjuvant therapy Angiogenesis Anti-angiogenics Antibody Antigen Avastin (bevacizumab) Benign A form of carcinoma that originates in glandular tissue.
More informationThe Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006
The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006 Overview Pancreatic ductal adenocarcinoma Pancreaticoduodenectomy
More informationLYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis
LYMPHOMA IN DOGS Lymphoma is a relatively common cancer in dogs. It is a cancer of lymphocytes (a type of white blood cell) and lymphoid tissues. Lymphoid tissue is normally present in many places in the
More informationTargeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
More informationLung Cancer: Diagnosis, Staging and Treatment
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
More informationInfluence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis
Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada Techniques,
More informationOmental mesothelioma as a diagnostic and therapeutic challenge: A case report
www.edoriumjournals.com Case in Images OPEN ACCESS Omental mesothelioma as a diagnostic and therapeutic challenge: A case report Cihan Akgul Ozmen, Yekta Tuzun, Hatice Ozturkmen Akay, Hasan Nazaroglu ABSTRACT
More informationHow To Treat A Uterine Sarcoma
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
More informationTranscript for Asbestos Information for the Community
Welcome to the lecture on asbestos and its health effects for the community. My name is Dr. Vik Kapil and I come to you from the Centers for Disease Control and Prevention, Agency for Toxic Substances
More informationMalignant Pleural Diseases Advances Clinicians Should Know F Gleeson
Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson The following relevant disclosures, conflicts of interest and/ or financial relationships exist related to this presentation: Consultant
More informationMESOTHELIOMA. Not Just a Late Night Commercial. Graciela Hoal, RN, MSN, ACNP-BC
MESOTHELIOMA Not Just a Late Night Commercial Graciela Hoal, RN, MSN, ACNP-BC Saturday Session Thoracic Surgery Nurse Practitioner Greater Los Angeles Veteran Affairs Objectives Course Objectives: Discuss
More informationOvarian cancer. A guide for journalists on ovarian cancer and its treatment
Ovarian cancer A guide for journalists on ovarian cancer and its treatment Contents Contents 2 3 Section 1: Ovarian Cancer 4 i. Types of ovarian cancer 4 ii. Causes and risk factors 5 iii. Symptoms and
More informationPeople Living with Cancer
Patient Guide ASCOInformation for People Living with Cancer ADVANCED LUNG CANCER TREATMENT Recommendations of the American Society of Clinical Oncology Welcome The American Society of Clinical Oncology
More informationSurgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND
Surgeons Role in Symptom Management A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Conditions PLEURAL Pleural effusion Pneumothorax ENDOBRONCHIAL Haemoptysis
More informationTestimony of. Dr. James Crapo. April 26, 2005
Testimony of Dr. James Crapo April 26, 2005 Written Statement of Dr. James D. Crapo, Professor of Medicine, National Jewish Medical and Research Center and University of Colorado Health Sciences Center
More informationInternational Journal of Case Reports in Medicine
International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 409830, 15 minipages. DOI:10.5171/2013.409830 www.ibimapublishing.com Copyright 2013 Andrew Thomas Low, Iain Smith and Simon
More informationLung Cancer. Public Outcomes Report. Submitted by Omar A. Majid, MD
Public Outcomes Report Lung Cancer Submitted by Omar A. Majid, MD Lung cancer is the most common cancer-related cause of death among men and women. It has been estimated that there will be 226,1 new cases
More informationFrancine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003
ASBESTOS Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003 Asbestosis Asbestosis is a model for other dust diseases as well as
More informationMalignant Mesothelioma Among Employees of a Connecticut Factory that Manufactured Friction Materials Using Chrysotile Asbestos
Ann. Occup. Hyg., Vol. 54, No. 6, pp. 692 696, 2010 Ó The Author 2010. Published by Oxford University Press on behalf of the British Occupational Hygiene Society doi:10.1093/annhyg/meq046 Malignant Mesothelioma
More informationAggressive lymphomas. Michael Crump Princess Margaret Hospital
Aggressive lymphomas Michael Crump Princess Margaret Hospital What are the aggressive lymphomas? Diffuse large B cell Mediastinal large B cell Anaplastic large cell Burkitt lymphoma (transformed lymphoma:
More informationHEALTH EFFECTS. Inhalation
Health Effects HEALTH EFFECTS Asbestos can kill you. You must take extra precautions when you work with asbestos. Just because you do not notice any problems while you are working with asbestos, it still
More informationCardiac Masses and Tumors
Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:
More informationMalignant Mesothelioma: A Study of Sixty-Six Cases
ORIGINAL RESEARCH ARTICLE Tanaffos (2006) 5(4), 59-63 2006 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran Malignant Mesothelioma: A Study of Sixty-Six Cases Ali Cheraghvandi
More informationAsbestos Brochure. Jim Wyatt - jwyatt@hamers.com Stephen Ball - sball@hamers.com. Freephone: 0800 591 999. www.hamers.com
Jim Wyatt - jwyatt@hamers.com Stephen Ball - sball@hamers.com Freephone: 0800 591 999 5 Earls Court, Priory Park East, Hull, HU4 7DY Tel: 01482 326666 Fax: 01482 324432 Aspect Court, 47 Park Square East,
More informationLuis D. Carcorze Soto, MD PGY-3
Luis D. Carcorze Soto, MD PGY-3 Peritoneal Surface Malignancies Peritoneum Patient Selection Operative Technique HIPEC EPIC Primary: Primary Peritoneal Carcinoma Malignant Peritoneal Mesothelioma Metastatic:
More informationBasic Data. 鍾 XX, female Age:59 y/o
Basic Data 鍾 XX, female Age:59 y/o Chief complain for evaluation of the left pleural mass Clinical course This 59 years old lady Hypertension for 3 years, under herbal control. An episode of high BP up
More informationFrequently Asked Questions
This fact sheet was written by the Agency for Toxic Substances and Disease Registry (ATSDR), a federal public health agency. ATSDR s mission is to serve the public by using the best science, taking responsive
More informationA 53-year-old woman presented in September 1991 to Adiyaman State Hospital with pain on the left side of the chest, dyspnoea, and dry cough.
Mesotelioma de pulmão - DR H. Ziya Ozel - Nerium oleander Nerium oleander Usou ANVIRZEL extrato da planta CASE REPORT Diagnosis: Mesothelioma - HD A 53-year-old woman presented in September 1991 to Adiyaman
More informationNon-Small Cell Lung Cancer
Non-Small Cell Lung Cancer About Your Lungs and Lung Cancer How do your lungs work? To understand lung cancer it is helpful to understand your lungs. Your lungs put oxygen into the blood, which the heart
More informationby Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H.
OCCUPATIONAL ASBESTOSIS AND RELATED DISEASES by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H. A 63-year-old man consulted an internist complaining of dyspnea on exertion. He reported the following:
More informationAsbestos Diseases. What Is Asbestos?
1 Asbestos Diseases What Is Asbestos? Asbestos is a term applied to a group of minerals formed into rock and mined in a similar way to coal. In this form, asbestos is made up of strong, fine and flexible
More information